Meta reported impressive Q2 2025 earnings, with shares rising over 11% in pre-market trading. The company’s revenue increased by 22% year-on-year to $47.5 billion, and earnings per share grew by 38% to $7.14 compared to Q2 2024.

Meta showcased a 5% increase in ad conversions on Instagram and 3% on Facebook, attributed to its GenAI-powered ad ranking systems. This marks the first measurable evidence of GenAI’s impact on Meta’s ad business, potentially influencing analysts to adjust their average revenue per mille models.

CFO Susan Li indicated increased AI infrastructure investment in 2026, signalling strong expected returns on infrastructure, especially in reducing latency and enhancing model throughput. If these yields are realised, it could lead to further stock gains.

However, EU regulatory risks pose potential challenges. The company’s Less Personalised Ads model could face scrutiny under the EU’s Digital Markets Act, possibly affecting ad revenue in the region. Signs of regulatory pressure could prompt a negative market reaction.

Despite a bullish breakout in the stock, regulatory uncertainties in Europe persist. While the earnings report inspires confidence, careful monitoring of European regulatory developments is crucial. Meta’s future may be influenced as much by EU regulation as by its internal innovations.

Following the impressive earnings report and the stock’s 11% pre-market surge, the immediate sentiment is clearly bullish. The strong performance, driven by AI-powered ad improvements, provides a solid reason to expect continued upward momentum. We should therefore consider strategies that benefit from a rising share price in the coming weeks.

We see that Meta’s 22% revenue growth is significantly outpacing the broader digital ad market, which recent data for Q2 2025 showed grew by only 12%. This suggests the company’s GenAI investment is creating a real competitive moat, justifying a positive outlook. The confirmed 5% ad conversion increase on Instagram is the kind of hard metric that supports a higher valuation.

This makes buying call options with September 2025 expirations an attractive way to trade this upward trend. For those of us who are more cautious, selling out-of-the-money puts could also be a sound strategy. This approach allows us to collect premium income based on the belief that the stock will hold above key support levels after this strong report.

However, we must balance this optimism with the serious regulatory risk coming from Europe. Recent reports from Brussels indicate that regulators are planning to scrutinize Meta’s “Less Personalised Ads” model in a mid-August meeting. This creates a specific, near-term event that could trigger significant stock price volatility.

Looking back, we remember how the stock dropped over 4% in a single day in early 2024 when the initial Digital Markets Act framework was detailed. With Europe having accounted for nearly 23% of Meta’s total ad revenue in 2024, any negative ruling from the EU could quickly undermine the positive earnings sentiment. This risk is not just theoretical; it has a clear historical precedent and a large financial weight.

To hedge against this possibility, we should consider buying some protective put options with late August or early September expirations. These would act as insurance against a sharp downturn caused by negative news from the EU. For those of us who believe a large price swing is imminent but are unsure of the direction, a long straddle could capture a significant move sparked by either AI optimism or regulatory fears.